Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Interleukin-2 significantly upregulates CD86 expression on T cells during cytokine therapy (131.35)

Ananta Paine, Hartmut Kirchner, Mathias Oelke, Rainer Blasczyk and Britta Eiz-Vesper
J Immunol April 1, 2010, 184 (1 Supplement) 131.35;
Ananta Paine
1Institute for Transfusion Medicine, Hannover Medical School, Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hartmut Kirchner
2Klinikum Hannover Siloah, Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mathias Oelke
3Johns Hopkins School of Medicine, Baltimore, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rainer Blasczyk
1Institute for Transfusion Medicine, Hannover Medical School, Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Britta Eiz-Vesper
1Institute for Transfusion Medicine, Hannover Medical School, Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 184 no. 1 Supplement 131.35

Published By 
The American Association of Immunologists, Inc.
Print ISSN 
0022-1767
Online ISSN 
1550-6606
History 
  • Published online May 5, 2016.

Copyright & Usage 
Copyright © 2010 by The American Association of Immunologists, Inc.

Author Information

  1. Ananta Paine1,
  2. Hartmut Kirchner2,
  3. Mathias Oelke3,
  4. Rainer Blasczyk1 and
  5. Britta Eiz-Vesper1
  1. 1Institute for Transfusion Medicine, Hannover Medical School, Hannover, Germany
  2. 2Klinikum Hannover Siloah, Hannover, Germany
  3. 3Johns Hopkins School of Medicine, Baltimore, MD

Article usage

Article usage: July 2016 to June 2022

AbstractFullPdf
Jul 2016200
Total 2016200
Mar 2017200
Apr 2017400
May 2017400
Jun 2017200
Jul 2017700
Aug 2017100
Sep 2017200
Oct 2017100
Total 20172300
Jan 2018600
Feb 2018200
Mar 2018200
May 2018200
Jun 2018300
Jul 2018100
Sep 2018200
Oct 2018200
Nov 2018500
Total 20182500
Jan 2019400
Feb 2019100
May 2019200
Jul 2019200
Sep 2019200
Dec 2019200
Total 20191300
Jan 2020400
Feb 20203900
Mar 20202100
Apr 20201200
May 2020100
Jul 2020100
Sep 2020200
Oct 20201400
Nov 2020300
Dec 2020200
Total 20209900
Feb 2021300
Mar 2021700
Apr 2021200
May 2021900
Jun 2021500
Jul 2021400
Aug 2021700
Sep 2021200
Oct 20214300
Nov 2021500
Dec 2021200
Total 20218900
Jan 2022200
Feb 2022200
Mar 2022300
Apr 2022200
May 2022300
Jun 2022300
Total 20221500
Total26600

Previous
Back to top

In this issue

The Journal of Immunology
Vol. 184, Issue 1 Supplement
April 2010
  • Table of Contents
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Interleukin-2 significantly upregulates CD86 expression on T cells during cytokine therapy (131.35)
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Interleukin-2 significantly upregulates CD86 expression on T cells during cytokine therapy (131.35)
Ananta Paine, Hartmut Kirchner, Mathias Oelke, Rainer Blasczyk, Britta Eiz-Vesper
The Journal of Immunology April 1, 2010, 184 (1 Supplement) 131.35;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Interleukin-2 significantly upregulates CD86 expression on T cells during cytokine therapy (131.35)
Ananta Paine, Hartmut Kirchner, Mathias Oelke, Rainer Blasczyk, Britta Eiz-Vesper
The Journal of Immunology April 1, 2010, 184 (1 Supplement) 131.35;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
  • Info & Metrics

Related Articles

Cited By...

More in this TOC Section

  • Polyelectrolyte microcapsules: antigen delivery vehicles for potent induction of CTL responses (131.34)
  • Long-term cytokine therapy with IL-15/IL-15Rα complexes leads to impaired NK cell function (131.11)
  • Adoptive co-transfer of tumor specific CD4+ T cells awakens host protective immunity to MHC-II- ovarian cancer through CD40-mediated licensing of dendritic cells and CCL5 secretion. (131.14)
Show more Cancer Immunotherapy

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606